Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability
“Maryland has one of the fastest growing biotechnology communities in the country with a world-class talent pool of scientists and researchers,” said
“It is exciting news that Horizon Therapeutics (HZNP) has chosen
“Maryland has quickly become a leader in cutting-edge medical research and development, thanks to companies like Horizon Therapeutics,” said Congressman
“I am thrilled that Horizon Therapeutics (HZNP) has decided to call
Horizon is being represented in the transaction by CBRE.
About Horizon
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.
Forward Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to the expected timing and benefits of the lease and Horizon’s plans and expectations related to its operations in
View source version on businesswire.com: https://www.businesswire.com/news/home/20220105006020/en/
Source: Horizon Therapeutics plc (HZNP)